Mendeley出力
＜学術雑誌論文＞
糖尿病網膜症の診断と治療の進歩
| 作成者 | |
|---|---|
| 本文言語 | |
| 出版者 | |
| 発行日 | |
| 収録物名 | |
| 巻 | |
| 号 | |
| 開始ページ | |
| 終了ページ | |
| 出版タイプ | |
| アクセス権 | |
| JaLC DOI | |
| 概要 | Diabetic retinopathy is clinically important for diagnosis of diabetes mellitus so that diabetic retinopathy can be reliably detected by fundus examination with the blood glucose level indicating mdia...betic typen. Diabetic retinopathy has been the leading cause of adult blindness in Japan. In diabetic retinopathy, long-lasting hyperglycemia causes vascular endothelial damage, increased vascular permeability toward progression of retinopathy. According to the Davis classification that is frequently used clinically, the pathophysiology, diagnosis, and treatment of diabetic retinopathy were classified into simple retinopathy, preproliferative retinopathy, and proliferative retinopathy. Diabetic retinopathy causes pathological changes in the neuroretina, and degenerative atrophy of the macula causes irreversible visual impairment. Following extensive ischemia and increased permeability of the retina, it is thought that neuronal degeneration occurs, leading to degeneration and atrophy of retinal tissue, especially in the macula. With anti-VEGF treatment, macula edema has been improved in the short term, but the pathology and molecular mechanism of retinal degeneration remain unknown. In Japan, outcomes of diabetic retinopathy treatment have improved due to recent remarkable progression of Ophthalmic imaging techniques such as optical coherence tomography (OCT), Minimally Invasive Vitrectomy Surgery (MIVS), and membrane staining adjuvant such as Brilliant Blue G during ocular surgery.続きを見る |
| 目次 | はじめに 1．疫学 2．病態と治療 3．検査と診断 4．治療と予後 5．眼科手術補助可視化剤 おわりに |
詳細
| PISSN | |
|---|---|
| NCID | |
| レコードID | |
| 査読有無 | |
| 主題 | |
| タイプ | |
| 登録日 | 2020.06.16 |
| 更新日 | 2021.03.03 |